FEBS Letters

Last updated

History

The initial idea of FEBS Letters as a journal for rapid communication of short reports in biochemistry, biophysics and molecular biology was proposed by the Secretary General of FEBS, W.J. Whelan, at the 4th FEBS Meeting held in Oslo in 1967. [1] [2] [3] After further discussions and preparations, the first issue of FEBS Letters appeared in July 1968 [4] with Satya Prakash Datta acting as Managing Editor. The initial editorial policy urged the authors to submit their manuscripts directly to a member of the editorial board, who independently evaluated them and, if needed, consulted external referees. [5] Apart from original research articles, early on FEBS Letters started publishing short reviews, hypotheses, discussion articles and meeting reports, as well as a number of supplements to regular issues extensively covering topical subjects. [3] In 2000 the handling of manuscripts was centralized and the editorial process amended and standardized. [6]

Satya Prakash Datta, who served as Managing Editor until 1985, was succeeded by Giorgio Semenza (1986-2000) and Matti Saraste (2000-2001). Between 2001 and 2021, the Managing Editor was Felix Wieland. [7] The current Editor in Chief is Michael Brunner.

The journal published 144 articles in 1968, and from then on steadily increased its output to reach an all-time high of 1733 published articles in 1999. [8]

Editorial and publishing concept

FEBS Letters staff consists of the Editor in Chief, the Editorial Office and the editorial board. The editorial board is composed of Academic Editors, who are active scientists working in different fields of the molecular biosciences.

In accordance with the Editor in Chief, the staff at the Editorial Office evaluates all submissions based on editorial policy and general scientific criteria. Manuscripts that pass through the pre-screening process are distributed to appropriate Academic Editors. The Academic Editors evaluate the manuscripts, supervise the peer-review process and make final decisions autonomously. The handling time from submission to first decision is on average 2.3 weeks. [6] Manuscripts accepted for publication are processed by Wiley and published online, bundled in 24 issues per year.

FEBS Letters follows a typical scientific society publishing model, where the income generated by the journal is used by FEBS to fund its activities, i.e. FEBS fellowships, advanced courses and workshops, congresses, and travel grants. [9]

Special Issues

Special Issues are collections of topical Review articles written by distinguished scientists covering the latest developments on specific topics in the molecular biosciences. Special Issue articles are commissioned, but, nevertheless, undergo the usual evaluation procedure exerted by the journal. Every year a Special Issue is directly associated with the FEBS Congress and consists of a compilation of Review articles contributed by speakers presenting their work at the congress.

Access

All accepted articles are published online by Wiley on behalf of FEBS. The FEBS Letters archive is completely digitalized and available back to the first issue in 1968. FEBS Letters follows a subscription-based model with a delayed and hybrid open access policy. All articles are made available to non-subscribers for free after 12 months, with Review articles being available for free immediately.

FEBS Letters Award

Every other year FEBS Letters offers a prize of €10,000 to the senior author of an outstanding Research Letter published in FEBS Letters during the previous two calendar years. The winning article is selected in an unbiased fashion[ clarification needed ] by a special Award Committee formed by appointed members of the editorial board plus one external member. The awardee is invited to give a plenary lecture at the FEBS Congress, where she/he is presented with the award. [10] The award has been presented regularly since 2003. [10]

Winners

YearNameAffiliation
2020Tim BartelsUK Dementia Research Institute at UCL, United Kingdom
2018David StuartUniversity of Oxford, United Kingdom
2016Kim Nasmyth
Jan Löwe		University of Oxford, United Kingdom
MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
2014Susanna Törnroth-HorsefieldLund University, Sweden
2013Susumu MitsutakeHokkaido University, Sapporo, Japan
2012Megumi Funakoshi-TagoKeio University, Tokyo, Japan
2011Shiro SuetsuguUniversity of Tokyo, Japan
2010Hideo IwaiUniversity of Helsinki, Finland
2009Frank SargentUniversity of Dundee, United Kingdom
2008Kaspar LocherETH Zurich, Switzerland
2007Noboru MizushimaTokyo Medical and Dental University Graduate School, Japan
2006Theresia StradalGBF, Braunschweig, Germany
2005Elke DeuerlingZBMH, Heidelberg, Germany
2004Jie-Oh LeeKAIST, Daejon, South Korea
2003Kun Ping LuHarvard Medical School, Boston, United States

Abstracting and indexing

The journal is indexed in:

Related Research Articles

<span class="mw-page-title-main">Glycogenin</span> Enzyme involved in converting glucose to glycogen

Glycogenin is an enzyme involved in converting glucose to glycogen. It acts as a primer, by polymerizing the first few glucose molecules, after which other enzymes take over. It is a homodimer of 37-kDa subunits and is classified as a glycosyltransferase.

<span class="mw-page-title-main">International Union of Biochemistry and Molecular Biology</span> International non-governmental organization concerned with biochemistry and molecular biology

The International Union of Biochemistry and Molecular Biology (IUBMB) is an international non-governmental organisation concerned with biochemistry and molecular biology. Formed in 1955 as the International Union of Biochemistry (IUB), the union has presently 79 member countries and regions. The Union is devoted to promoting research and education in biochemistry and molecular biology throughout the world, and gives particular attention to localities where the subject is still in its early development.

<span class="mw-page-title-main">Federation of European Biochemical Societies</span>

The Federation of the European Biochemical Societies (FEBS) is an international scientific society promoting activities in biochemistry, molecular biology and related research areas in Europe and neighbouring regions. It was founded in 1964 and includes over 35,000 members across 39 Constituent Societies.

<i>Journal of Biological Chemistry</i> Academic journal

The Journal of Biological Chemistry (JBC) is a weekly peer-reviewed scientific journal that was established in 1905. Since 1925, it is published by the American Society for Biochemistry and Molecular Biology. It covers research in areas of biochemistry and molecular biology. The editor is Alex Toker. As of January 2021, the journal is fully open access. In press articles are available free on its website immediately after acceptance.

<span class="mw-page-title-main">Complement component 1r</span> Protein-coding gene in humans

Complement C1r subcomponent is a protein involved in the complement system of the innate immune system. In humans, C1r is encoded by the C1R gene.

Renal tissue kallikrein is an enzyme.

<span class="mw-page-title-main">Yuri Ovchinnikov (biochemist)</span> Soviet chemist (1934–1988)

Yuri Anatolyevich Ovchinnikov was a Soviet chemist who contributed to bioorganic chemistry and biochemistry. He was elected in 1970 as a full member of the USSR Academy of Sciences and subsequently became the youngest vice president of the academy in its history (1974-1988). He was elected to the American Philosophical Society in 1977. He was also president of the Federation of European Biochemical Societies (1984-1986), Director of the Institute of Bioorganic Chemistry in Moscow (1970-1988) and professor at Moscow State University. From 1972 through to 1984 he served concomitantly as head of the Laboratory of Protein Chemistry at the USSR Academy of Sciences' Institute of Protein.

<span class="mw-page-title-main">Actin, alpha skeletal muscle</span> Protein-coding gene in the species Homo sapiens

Actin, alpha skeletal muscle is a protein that in humans is encoded by the ACTA1 gene.

<span class="mw-page-title-main">GNAI2</span> Protein-coding gene in humans

Guanine nucleotide-binding protein G(i), alpha-2 subunit is a protein that in humans is encoded by the GNAI2 gene.

<span class="mw-page-title-main">Cathepsin L1</span> Protein-coding gene in the species Homo sapiens

Cathepsin L1 is a protein that in humans is encoded by the CTSL1 gene. The protein is a cysteine cathepsin, a lysosomal cysteine protease that plays a major role in intracellular protein catabolism.

ATPase, Na<sup>+</sup>/K<sup>+</sup> transporting, alpha 1 Protein-coding gene in the species Homo sapiens

Sodium/potassium-transporting ATPase subunit alpha-1 is an enzyme that in humans is encoded by the ATP1A1 gene.

<span class="mw-page-title-main">SCG5</span> Protein-coding gene in humans

Neuroendocrine protein 7B2 is a protein that in humans is encoded by the SCG5 gene. The protein expressed by this gene is widely distributed in neuroendocrine tissues. It functions as a chaperone protein for the proprotein convertase PC2 by blocking the aggregation of this protein, and is required for the production of an active PC2 enzyme. It is an intrinsically disordered protein that may also function as a chaperone for other aggregating secretory proteins in addition to proPC2. 7B2 has been identified in vertebrates and in invertebrates as low as flatworms and insects. It is also called Sgne1 and Secretogranin V. In C. elegans, it was originally called e7B2 and then renamed Seven B Two. There is a Pfam entry for this protein: Secretogranin_V (PF05281).

<span class="mw-page-title-main">USP5</span> Protein-coding gene in the species Homo sapiens

Ubiquitin specific peptidase 5 is an enzyme that in humans is encoded by the USP5 gene.

<span class="mw-page-title-main">ADH7</span> Protein-coding gene in the species Homo sapiens

Alcohol dehydrogenase class 4 mu/sigma chain is an enzyme that in humans is encoded by the ADH7 gene.

<i>Annual Review of Biochemistry</i> Academic journal

Annual Review of Biochemistry is an annual peer-reviewed scientific journal published by Annual Reviews, a nonprofit scientific publisher. Its first volume was published in 1932, and its founding editor was J. Murray Luck. The current editor is Roger D. Kornberg. The journal focuses on molecular biology and biological chemistry review articles. As of 2024, Journal Citation Reports gives the journal an impact factor of 12.1, ranking it fourteenth out of 313 journals in the category "Biochemistry and Molecular Biology". As of 2023, it is being published as open access, under the Subscribe to Open model.

<span class="mw-page-title-main">Ecadotril</span> Chemical compound

Ecadotril is a neutral endopeptidase inhibitor ((NEP) EC 3.4.24.11) and determined by the presence of peptidase family M13 as a neutral endopeptidase inhibited by phosphoramidon. Ecadotril is the (S)-enantiomer of racecadotril. NEP-like enzymes include the endothelin-converting enzymes. The peptidase M13 family believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides, neprilysin is another member of this group, in the case of the metallopeptidases and aspartic, the nucleophiles clan or family for example MA, is an activated water molecule. The peptidase domain for members of this family also contains a bacterial member and resembles that of thermolysin the predicted active site residues for members of this family and thermolysin occur in the motif HEXXH. Thermolysin complexed with the inhibitor (S)-thiorphan are isomeric thiol-containing inhibitors of endopeptidase EC 24-11 (also called "enkephalinase").

<span class="mw-page-title-main">Momordin (protein)</span>

Momordin or α-momorcharin is one of several related proteins isolated from several plants of the genus Momordica, which includes the bitter melon and the balsam apple.

William Joseph Whelan FRS was a British-born American biochemist. He was professor and chair of biochemistry and molecular biology at the Miller School of Medicine at the University of Miami. He founded the annual Miami Winter Symposium in 1967 and was chief editor of the journal IUBMB Life.

<span class="mw-page-title-main">Joan Guinovart</span> Spanish pharmacist and scientist (1947–2025)

Joan Josep Guinovart Cirera was a Spanish biochemist known for research on glycogen and liver glycogen synthase, as well as for work in FEBS, IUBMB and the Spanish Society of Biochemistry and Molecular Biology.

References

  1. ↑ Whelan, WJ (1974). "The foundation and early years of FEBS". FEBS Letters. 40: suppl:S154–9. doi:10.1016/0014-5793(74)80698-8. PMID   4153118. S2CID   44599117.
  2. ↑ Whelan, WJ (1986). "How FEBS Letters began". FEBS Letters. 194 (1): v–vii. doi: 10.1016/0014-5793(86)80038-2 .
  3. 1 2 Datta, SP (1988). "The early days of FEBS Letters". FEBS Letters. 233 (2): iii. doi:10.1016/0014-5793(88)80428-9.
  4. ↑ Šorm, F (1968). "Foreword". FEBS Letters. 1 (1): I. doi:10.1016/0014-5793(68)80002-X. PMID   11945259. S2CID   221304574.
  5. ↑ Datta, SP (1974). "European Journal of Biochemistry". FEBS Letters. 40: S174. doi: 10.1016/0014-5793(74)80705-2 . S2CID   221417645.
  6. 1 2 FEBS Letters (2012). "Editorial Office".{{cite journal}}: Cite journal requires |journal= (help)
  7. ↑ Feldmann, Horst (2004). "FEBS Letters". Forty years of FEBS: 1964 to 2003: a memoir. Blackwell. pp. 97–98. ISBN   978-1405117647.
  8. ↑ "Scopus". Elsevier. Retrieved 26 September 2012.
  9. ↑ "FEBS Publications" . Retrieved 18 October 2012.
  10. 1 2 "FEBS Letters Award". doi:10.1002/(ISSN)1873-3468 . Retrieved 31 May 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.